Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
SYT - SYLA Technologies Co Ltd ADR - Stock Price Chart
TickerSYT [NASD]
CompanySYLA Technologies Co Ltd ADR
CountryJapan
IndustrySoftware - Application
Market Cap84.89MEPS (ttm)-
P/E-EPS this Y-34.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-41.82%
Dividend0.51%Sales Q/Q4.44%
Insider Own-Inst Own0.00%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume6.24K52W Range1.46 - 8.74
Apr-25-24 09:00AM SYLA Technologies Announces Gain on Sales of Investment Securities (GlobeNewswire)
Apr-11-24 10:00AM CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA (PR Newswire)
Apr-01-24 09:00AM SYLA Announces ietty's Membership Has Surpassed 300,000 (GlobeNewswire) -5.18%
Mar-28-24 09:00AM SYLA Technologies Subsidiary SYLA Solar Announces Issuance of Series 1 Unsecured Bonds (GlobeNewswire)
Mar-04-24 04:05PM SYLA Technologies Subsidiary SYLA Solar Announces Comprehensive Business Alliance with LIVE THE CREATIVE (GlobeNewswire)
Jan-31-24 04:30PM SYLA Technologies Announces Its Growth Strategy Centered on Mergers and Acquisitions (GlobeNewswire)
Jan-25-24 09:00AM SYLA Technologies Announces FY2024 Financial Guidance and Upward Revision of FY2023 Dividend Forecast (GlobeNewswire)
Jan-23-24 09:00AM SYLA Technologies Enters into a Capital and Business Alliance Agreement with RIBERESUTE (GlobeNewswire)
Jan-16-24 09:00AM SYLA Sells Four SYFORME Brand Condominiums to a Private Fund Managed by BlackRock's Real Estate Business (GlobeNewswire) -15.77%
Jan-12-24 09:00AM SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares (GlobeNewswire) +33.82%
MNDR - Mobile health Network Solutions - Stock Price Chart
TickerMNDR [NASD]
CompanyMobile health Network Solutions
CountrySingapore
IndustryHealth Information Services
Market Cap728.62MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own53.46%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.30%Earnings-
Analyst Recom1.00Target Price7.00
Avg Volume5.32M52W Range4.79 - 29.50
Apr-30-24 07:45AM Mobile-health Network Solutions Opens New Retail Pharmacy (GlobeNewswire)
Apr-23-24 09:00AM Mobile-health Network and Online Pharmacy, Lifepack, Sign Partnership Facilitating Cooperation in Singapore and Indonesia (GlobeNewswire)
Apr-22-24 09:00AM APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 (GlobeNewswire) -12.54%
Apr-17-24 08:55AM Mobile-health Network Solutions Ranked Number 41 in Financial Times Listing of 500 High-growth Asia-Pacific Companies (GlobeNewswire)
Apr-15-24 08:30AM Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange (GlobeNewswire) +11.00%
Apr-12-24 07:28PM Mobile-health Network Solutions Announces Closing of Initial Public Offering (GlobeNewswire) +47.06%
Apr-09-24 06:30PM Mobile-health Network Solutions Announces Pricing of $9 Million Initial Public Offering (GlobeNewswire)
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap3.50MEPS (ttm)-27.02
P/E-EPS this Y49.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.13%
P/S8.33EPS next 5Y-
P/B4.62EPS Q/Q30.27%
Dividend-Sales Q/Q-
Insider Own8.89%Inst Own7.12%
Insider Trans7.27%Inst Trans-
Short Float3.20%EarningsMar 19/a
Analyst Recom2.00Target Price11.00
Avg Volume466.82K52W Range1.30 - 13.20
Apr-30-24 02:37PM Top Midday Gainers (MT Newswires) +55.88%
07:47AM Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? (InvestorPlace)
07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
07:00AM Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Apr-01-24 09:15AM Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer (GlobeNewswire)
Mar-20-24 10:05AM Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 08:53PM CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023 (InvestorPlace) -6.37%
04:05PM Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-13-24 04:05PM Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-07-24 09:15AM Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire) +5.06%
CTMX - CytomX Therapeutics Inc - Stock Price Chart
TickerCTMX [NASD]
CompanyCytomX Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap347.40MEPS (ttm)-0.02
P/E-EPS this Y-3686.00%
Forward P/E-EPS next Y-11.90%
PEG-EPS past 5Y67.21%
P/S3.43EPS next 5Y-0.90%
P/B-EPS Q/Q109.36%
Dividend-Sales Q/Q32.22%
Insider Own1.84%Inst Own48.12%
Insider Trans-5.72%Inst Trans-20.06%
Short Float5.41%EarningsMar 11/a
Analyst Recom2.86Target Price2.85
Avg Volume928.95K52W Range1.04 - 2.86
May-01-24 12:11PM Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally (InvestorPlace) +214.72%
11:43AM Why Is CytomX (CTMX) Stock Up 180% Today? (InvestorPlace)
08:00AM CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024 (GlobeNewswire)
Apr-08-24 08:00AM CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors (GlobeNewswire)
Apr-03-24 08:00AM CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY T-Cell Engaging Bispecific (TCB) Collaboration with Astellas (GlobeNewswire)
Mar-21-24 08:00AM CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors (GlobeNewswire)
Mar-18-24 08:00AM CytomX Therapeutics Announces Milestone Achievement in PROBODY T-Cell Engaging Bispecific (TCB) Collaboration with Astellas (GlobeNewswire)
Mar-12-24 09:12AM Why Is CytomX Therapeutics (CTMX) Stock Down 18% Today? (InvestorPlace) -14.34%
08:30AM CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:46AM Q4 2023 CytomX Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
BITE - Bite Acquisition Corp - Stock Price Chart
TickerBITE [AMEX]
CompanyBite Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap77.60MEPS (ttm)-0.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.04EPS Q/Q-59.52%
Dividend-Sales Q/Q-
Insider Own75.19%Inst Own25.57%
Insider Trans0.00%Inst Trans21.11%
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume24.87K52W Range9.20 - 12.81
Feb-21-24 08:00AM Bite Acquisition Corp. Receives Commencement of Delisting Notice from the NYSE (PR Newswire)
May-30-23 12:41PM Correction: Above Food Corp. to Present at Gravitas' 4th Los Angeles Summit (News Direct)
07:01AM Above Food Corp. to Present at Gravitas' 4th Los Angeles Summit (News Direct)
May-15-23 07:01AM Above Food Announces Participation in BMO Capital Markets' Global Farm to Market Conference (News Direct)
May-01-23 07:30AM Above Food Corp., a Vertically Integrated Specialty Ingredients and Food Company, to List on NYSE Through Business Combination with Bite Acquisition Corp. (Business Wire)
Feb-08-23 08:11PM Bite Acquisition Corp. Announces Transfer to NYSE American (PR Newswire)
Jan-03-23 03:03PM Bite Acquisition Corp. Announces Board Resignations (PR Newswire)
Dec-05-22 05:18PM Bite Acquisition Corp. Announces Amendment and Supplement to Definitive Proxy Statement (PR Newswire)
Nov-16-22 10:47AM Bite Acquisition Corp. (NYSE:BITE) is largely controlled by institutional shareholders who own 67% of the company (Simply Wall St.)
May-24-22 02:43PM ALURX, THE WELLNESS HUB, WELCOMES DR. ILYAS AND DR. PERAINO TO ITS TRUSTED MEDICAL & EXPERT COUNCIL (PR Newswire)
BENF - Beneficient - Stock Price Chart
TickerBENF [NASD]
CompanyBeneficient
CountryUSA
IndustryAsset Management
Market Cap45.61MEPS (ttm)-279.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S77.31EPS next 5Y-
P/B-EPS Q/Q-363081.65%
Dividend-Sales Q/Q-
Insider Own95.26%Inst Own3.07%
Insider Trans1.91%Inst Trans-
Short Float2.94%EarningsFeb 13/a
Analyst Recom-Target Price-
Avg Volume125.79K52W Range3.26 - 1320.00
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -9.72%
Apr-22-24 07:00AM Beneficient Responds to Claims Made by GWG Litigation Trustee (GlobeNewswire) +22.45%
Apr-16-24 07:00AM Beneficient Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price (GlobeNewswire) -17.78%
Apr-15-24 04:15PM Beneficient to Participate in the Planet MicroCap Showcase on May 1-2, 2024 (GlobeNewswire) -7.60%
Mar-06-24 05:00PM Beneficient Enters into New Liquidity Transaction with ff Venture Capital (GlobeNewswire)
Feb-23-24 08:21AM Why Is Beneficient (BENF) Stock Up 25% Today? (InvestorPlace) -10.05%
Feb-14-24 08:21AM Beneficient (NASDAQ:BENF) Q3 2024 Earnings Call Transcript (Insider Monkey)
Feb-13-24 04:05PM Beneficient Reports Results for Third Quarter Fiscal 2024 (GlobeNewswire)
Feb-12-24 07:00AM Beneficient Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence (GlobeNewswire)
Feb-08-24 04:05PM Beneficient Announces Third Quarter Fiscal 2024 Earnings Release and Webcast (GlobeNewswire) -6.38%
BCAB - BioAtla Inc - Stock Price Chart
TickerBCAB [NASD, RUT]
CompanyBioAtla Inc
CountryUSA
IndustryBiotechnology
Market Cap162.13MEPS (ttm)-2.58
P/E-EPS this Y25.09%
Forward P/E-EPS next Y8.17%
PEG-EPS past 5Y-25.30%
P/S-EPS next 5Y-
P/B2.29EPS Q/Q10.43%
Dividend-Sales Q/Q-
Insider Own19.40%Inst Own54.38%
Insider Trans0.92%Inst Trans10.10%
Short Float13.97%EarningsMar 26/a
Analyst Recom1.00Target Price11.50
Avg Volume554.69K52W Range1.24 - 4.07
Apr-24-24 04:35PM BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Mar-27-24 10:07AM BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript (Insider Monkey) +14.95%
07:56AM Q4 2023 Bioatla Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 09:54PM BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023 (InvestorPlace) +29.18%
05:33PM BioAtla Inc (BCAB) Posts Q4 and Full Year 2023 Financial Results (GuruFocus.com)
04:01PM BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress (GlobeNewswire)
Mar-19-24 08:00AM BioAtla to Announce Fourth Quarter and Full-Year 2023 Financial Results and Provide Business Highlights on March 26, 2024 (GlobeNewswire) +5.13%
Mar-07-24 08:00AM BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Dec-20-23 08:00AM BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-13-23 08:00AM BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types (GlobeNewswire) +23.26%
HAO - Haoxi Health Technology Ltd. - Stock Price Chart
TickerHAO [NASD]
CompanyHaoxi Health Technology Ltd.
CountryChina
IndustryAdvertising Agencies
Market Cap224.44MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.00%Earnings-
Analyst Recom-Target Price-
Avg Volume40.95K52W Range4.03 - 8.83
Jan-30-24 04:05PM Haoxi Health Technology Limited Announces Closing of $9,600,000 Initial Public Offering (GlobeNewswire) +62.39%
Jan-25-24 04:31PM Haoxi Health Technology Limited Announces Pricing of Its Initial Public Offering (GlobeNewswire)
SWVL - Swvl Holdings Corp - Stock Price Chart
TickerSWVL [NASD]
CompanySwvl Holdings Corp
CountryUnited Arab Emirates
IndustrySoftware - Application
Market Cap77.75MEPS (ttm)8.09
P/E1.41EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.90EPS next 5Y-
P/B9.62EPS Q/Q-90760.29%
Dividend-Sales Q/Q-
Insider Own46.03%Inst Own0.63%
Insider Trans0.00%Inst Trans-
Short Float1.83%EarningsDec 27/b
Analyst Recom3.00Target Price37.50
Avg Volume116.38K52W Range0.62 - 21.94
May-01-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -16.42%
Apr-30-24 06:00AM Swvl Records $3.1m Net Profit, 13% Net Margin, and an Eightfold Growth in Gross Profit (GlobeNewswire) +35.38%
Mar-08-24 05:20AM 15 Cities with the Worst Public Transportation in the US (Insider Monkey) -22.70%
Mar-06-24 03:04PM 15 European Cities with the Best Public Transportation (Insider Monkey) +11.39%
Dec-27-23 06:00AM Swvl Reports First Half 2023 Financial Results (GlobeNewswire) +36.07%
Dec-26-23 04:05PM Swvl Reports Receipt of Nasdaq Minimum Bid Price Notification (GlobeNewswire)
Sep-13-23 04:50AM Swvl Sells one of its Subsidiaries, Urbvan, to Kolors, To Leverage Sale Proceeds for Enhanced Strategic Expansion (GlobeNewswire) +11.65%
Jul-20-23 04:05PM Swvl Obtains Extension for Filing of Annual Report on Form 20-F and Receives Approval to Transfer to The Nasdaq Capital Market (GlobeNewswire)
Jun-20-23 06:00AM Swvl Regains Compliance with NASDAQ Continued Listing Requirements Relating to Audit Committee (GlobeNewswire) +5.26%
May-23-23 04:05PM Swvl Appoints Ayman Ismail to Board of Directors as Independent Member and Chairperson of Audit Committee (GlobeNewswire)
PMN - ProMIS Neurosciences Inc. - Stock Price Chart
TickerPMN [NASD]
CompanyProMIS Neurosciences Inc.
CountryCanada
IndustryBiotechnology
Market Cap36.38MEPS (ttm)-1.23
P/E-EPS this Y35.51%
Forward P/E-EPS next Y26.09%
PEG-EPS past 5Y11.39%
P/S-EPS next 5Y-
P/B9.65EPS Q/Q79.12%
Dividend-Sales Q/Q-
Insider Own24.24%Inst Own12.24%
Insider Trans0.00%Inst Trans-
Short Float0.16%EarningsApr 01/a
Analyst Recom1.00Target Price19.28
Avg Volume17.32K52W Range0.95 - 8.95
Apr-30-24 07:00AM ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies (GlobeNewswire)
Apr-09-24 07:00AM ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS (GlobeNewswire)
Apr-04-24 07:00AM ProMIS Neurosciences to Present in Upcoming Investor Conferences in April (GlobeNewswire)
Apr-01-24 10:53PM PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q4 2023 (InvestorPlace) +7.33%
04:15PM ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights (GlobeNewswire)
Mar-11-24 07:00AM ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio (GlobeNewswire)
Feb-22-24 07:00AM ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference (GlobeNewswire) -10.14%
Jan-22-24 07:00AM ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine (GlobeNewswire) +7.24%
Jan-08-24 07:00AM ProMIS Neurosciences Issues Letter to Shareholders (GlobeNewswire) +5.45%
Jan-03-24 07:00AM ProMIS Neurosciences, Inc. Announces Leadership Transition (GlobeNewswire) -7.82%
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.